Finance

Beta
Lists
VERA:NASDAQ
Vera Therapeutics, Inc
$43.04
+1.37%
(+0.58) 1D
Jun 29, 3:24:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
$43.41
High
$44.04
Low
$41.41
Mkt. cap
3.08B
Avg. vol.
1.37M
Volume
2.34M
52-wk high
$56.04
52-wk low
$19.07
EPS
-$5.54
Beta
0.93
Shares outstanding
71.78M
No. of employees
339
Open
$43.41
High
$44.04
Low
$41.41
Mkt. cap
3.08B
Avg. vol.
1.37M
Volume
2.34M
52-wk high
$56.04
52-wk low
$19.07
EPS
-$5.54
Beta
0.93
Shares outstanding
71.78M
No. of employees
339
News stories
From sources across the web
About Vera Therapeutics, Inc
CEO-
Employees339
Founded2016
HeadquartersBrisbane, California, United States
SectorBiotechnology
Websiteveratx.com
Analyst ratings
Based on 13 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
12
Hold
1
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current $43.04
$110.00 (+155.58%)
Average
$80.09 (+86.08%)
Lowest
$35.00 (-18.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Deschner
Raymond James
Buy
Maintained
-
-
06/24/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$70.00
+62.6%
06/11/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
$100.00
+132.3%
06/04/2026
Arthur He CFA
H.C. Wainwright
Buy
Maintained
$110.00
+155.6%
06/05/2026
Paul Choi
Goldman Sachs
Buy
Maintained
$90.00
+109.1%
06/05/2026
Andy Chen
Wolfe Research
Buy
Maintained
$88.00
+104.5%
06/02/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$56.00
+30.1%
06/05/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$90.00
+109.1%
06/02/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
06/02/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$86.00
+99.8%
05/22/2026
Dina Ramadane
Bank of America Securities
Buy
Reiterated
$65.00
+51%
05/22/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$91.00
+111.4%
05/15/2026
Unknown Analyst
Wedbush
Hold
Maintained
$35.00
-18.7%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
58.20M
56.47M
59.31M
86.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.95M
27.46M
34.90M
39.12M
Operating expense
80.14M
83.93M
94.21M
125.13M
Total operating expenses
80.14M
83.93M
94.21M
125.13M
Operating income
-80.14M
-83.93M
-94.21M
-125.13M
Other non operating income
-836.00K
-137.00K
-303.00K
-32.00K
EBT including unusual items
-76.53M
-80.29M
-91.10M
-121.03M
EBT excluding unusual items
-76.53M
-80.29M
-90.90M
-120.63M
Income tax expense
-
-
1.00K
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-76.53M
-80.29M
-91.10M
-121.03M
Net profit margin
-
-
-
-
Earnings per share
-1.20
-1.26
-1.39
-1.69
Interest and investment income
6.32M
5.74M
5.52M
6.36M
Interest expense
-1.87M
-1.96M
-1.90M
-1.82M
Net interest expenses
4.45M
3.78M
3.61M
4.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
-80.02M
-83.80M
-94.07M
-124.99M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer